Manufacture of pharmaceutical preparations
VISTIN PHARMA AS
Revenue 2024
NOK 429.5m
Operating profit
NOK 91.3m
Equity
NOK 174.3m
Incorporated
2014
Employees
78
Share capital
NOK 100,000
Key figures · 2024
Current ratio
0.69
Equity ratio
46.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 21.3% | |
| Net margin (%%) | 15.4% | |
| Return on assets (%%) | 24.3% | |
| Likviditet | ||
| Current ratio | 0.69 | |
| Working capital | −60.8m | |
| Soliditet | ||
| Equity ratio (%%) | 46.4% | |
| Debt-to-equity ratio | 1.16 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.